PA GOODDOCTOR has announced a strategic collaboration with Pfizer China, aiming to establish a dual closed-loop system that integrates healthcare services, pharmaceuticals, insurance, and patient management.

This partnership seeks to address challenges in accessibility to innovative medicines, payment security, and coordinated disease management both inside and outside hospital settings by leveraging the combined strengths of both companies.

The collaboration will focus on two key areas: creating a commercial closed-loop for medicine and insurance, and establishing a comprehensive patient journey management system.

Within the commercial framework, the partners will explore innovative insurance products for specific disease categories.

For patient management, the initiative will build a full-cycle service system covering disease screening, patient education, standardized diagnosis and treatment, precise medication, and long-term follow-up.

Future cooperative efforts will extend to fields including oncology, rare diseases, vaccines, and metabolic health.

Leadership from both companies expressed that this deep integration represents a core direction for the development of internet-based healthcare, with the goal of delivering high-value, sustainable health management solutions to users.